Abstract
PET imaging of cannabinoid type 1 receptor (CB1) is important for assessment of the receptor role in many neurological and psychiatric disorders. 5-(4-(2-[18F]fluoroethoxy)phenyl)-1-(2,4-dichlorophenyl)-4-cyano-N-(piperidin-1- yl)-1H-pyrazole-3-carboxamide ([18F]JHU88868), an analog of the radiotracer of choice for PET imaging of CB1 receptors in humans [11C]JHU75528 ([11C]OMAR), with a longer half-life exhibits high CB1 binding affinity (Ki = 16, 17 nM) and moderate lipophilicity. An efficient synthesis of JHU88868 and its bromoethoxy derivative for radiolabeling are presented. [18F]-2 ([18F]JHU88868) was prepared in one step by a Kryptofix-assisted radiofluorination of the corresponding bromo-precursor in DMSO solution at 135°C using a nucleophilic fluorination radiochemistry box with radiochemical yield of 1-5 %, radiochemical purity greater than 95% and the average specific activity of 4000 mCi/μmol at the end-ofsynthesis.
Keywords: Cannabinoid receptor, positron emission tomography (PET), radiofluorination
Current Radiopharmaceuticals
Title: 5-(4-(2-[ F]fluoroethoxy)phenyl)-1-(2,4-dichlorophenyl)-4-cyano-N- (piperidin-1-yl)-1H-pyrazole-3-carboxamide ([ F]JHU88868), a Novel Radioligand for PET Imaging of Cannabinoid Type 1 Receptors
Volume: 2 Issue: 3
Author(s): Yongjun Gao, Hayden T. Ravert, Robert F. Dannals and Andrew G. Horti
Affiliation:
Keywords: Cannabinoid receptor, positron emission tomography (PET), radiofluorination
Abstract: PET imaging of cannabinoid type 1 receptor (CB1) is important for assessment of the receptor role in many neurological and psychiatric disorders. 5-(4-(2-[18F]fluoroethoxy)phenyl)-1-(2,4-dichlorophenyl)-4-cyano-N-(piperidin-1- yl)-1H-pyrazole-3-carboxamide ([18F]JHU88868), an analog of the radiotracer of choice for PET imaging of CB1 receptors in humans [11C]JHU75528 ([11C]OMAR), with a longer half-life exhibits high CB1 binding affinity (Ki = 16, 17 nM) and moderate lipophilicity. An efficient synthesis of JHU88868 and its bromoethoxy derivative for radiolabeling are presented. [18F]-2 ([18F]JHU88868) was prepared in one step by a Kryptofix-assisted radiofluorination of the corresponding bromo-precursor in DMSO solution at 135°C using a nucleophilic fluorination radiochemistry box with radiochemical yield of 1-5 %, radiochemical purity greater than 95% and the average specific activity of 4000 mCi/μmol at the end-ofsynthesis.
Export Options
About this article
Cite this article as:
Gao Yongjun, Ravert T. Hayden, Dannals F. Robert and Horti G. Andrew, 5-(4-(2-[ F]fluoroethoxy)phenyl)-1-(2,4-dichlorophenyl)-4-cyano-N- (piperidin-1-yl)-1H-pyrazole-3-carboxamide ([ F]JHU88868), a Novel Radioligand for PET Imaging of Cannabinoid Type 1 Receptors, Current Radiopharmaceuticals 2009; 2 (3) . https://dx.doi.org/10.2174/1874471010902030195
DOI https://dx.doi.org/10.2174/1874471010902030195 |
Print ISSN 1874-4710 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4729 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Children and War: A Personal Perspective on Childhood in World War II and Post-war Germany
Adolescent Psychiatry Epidemiological Aspects of Stroke in Very Old Patients
Cardiovascular & Hematological Disorders-Drug Targets Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Optimal Sedation for the Ventilation of Critically Ill Patients
Current Respiratory Medicine Reviews MR Spectroscopy Findings of the Basal Ganglia in Bipolar Disorders: a Systematic Review
Current Psychiatry Reviews Association between the Regulator of G-protein Signaling 9 Gene and Patients with Methamphetamine Use Disorder and Schizophrenia
Current Neuropharmacology Dl-3-n-Butylphthalide (NBP): A Promising Therapeutic Agent for Ischemic Stroke
CNS & Neurological Disorders - Drug Targets Chronic Pain: Cytokines, Lymphocytes and Chemokines
Inflammation & Allergy - Drug Targets (Discontinued) Evidence of 2 Populations of Mephedrone Abusers by Hair Testing. Application to 4 Forensic Expertises
Current Neuropharmacology Selective Divalent Copper Chelation for the Treatment of Diabetes Mellitus
Current Medicinal Chemistry Down Regulated Expression of Claudin-1 and Claudin-5 and Up Regulation of β-Catenin: Association with Human Glioma Progression
CNS & Neurological Disorders - Drug Targets The Molecular and Cellular Basis of Atherosclerosis and Plaque Rupture
Current Cardiology Reviews Micronutrients at the Interface Between Inflammation and Infection Ascorbic Acid and Calciferol. Part 1: General Overview with a Focus on Ascorbic Acid
Inflammation & Allergy - Drug Targets (Discontinued) Neurocognitive Correlates in Driving Under the Influence of <I>Cannabis</i>
CNS & Neurological Disorders - Drug Targets Mitochondria in Chronic Liver Disease
Current Drug Targets Regeneration in a Degenerating Brain: Potential of Allopregnanolone as a Neuroregenerative Agent
Current Alzheimer Research The Pharmacological Management of Intrahepatic Cholestasis of Pregnancy
Current Clinical Pharmacology The Chemistry and Bio-Medicinal Significance of Pyrimidines & Condensed Pyrimidines
Current Topics in Medicinal Chemistry A Critical Review of Laboratory-Based Studies Examining the Relationships of Social Anxiety and Alcohol Intake
Current Drug Abuse Reviews